IRIS
DI BONAVENTURA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.944
EU - Europa 6.080
AS - Asia 3.639
SA - Sud America 325
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 17.031
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.868
CN - Cina 1.262
SG - Singapore 1.244
IT - Italia 1.206
IE - Irlanda 994
UA - Ucraina 984
GB - Regno Unito 800
SE - Svezia 699
TR - Turchia 695
FR - Francia 454
DE - Germania 383
BR - Brasile 281
IN - India 228
FI - Finlandia 199
RU - Federazione Russa 184
VN - Vietnam 49
HK - Hong Kong 43
AT - Austria 36
MX - Messico 34
CA - Canada 33
JP - Giappone 23
CZ - Repubblica Ceca 22
ES - Italia 22
BD - Bangladesh 19
NL - Olanda 19
BE - Belgio 18
CH - Svizzera 16
AR - Argentina 13
PL - Polonia 12
EU - Europa 11
IQ - Iraq 10
ZA - Sudafrica 10
IR - Iran 9
EC - Ecuador 7
IL - Israele 7
KR - Corea 7
TH - Thailandia 6
UZ - Uzbekistan 6
VE - Venezuela 6
LB - Libano 5
PY - Paraguay 5
CL - Cile 4
GR - Grecia 4
LT - Lituania 4
MA - Marocco 4
PE - Perù 4
RS - Serbia 4
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
JO - Giordania 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
TW - Taiwan 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CO - Colombia 2
KE - Kenya 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 17.031
Salva come PNG Salva come JPEG
Città #
Chandler 1.323
Jacksonville 1.198
Dublin 990
Singapore 792
Dearborn 642
Southend 574
Princeton 475
Izmir 376
Nanjing 342
Ashburn 238
Beijing 234
Chieti 200
Wilmington 184
Cambridge 182
Santa Clara 149
The Dalles 131
Nanchang 125
Altamura 120
Ann Arbor 113
Boardman 89
Kunming 70
Los Angeles 67
Rome 64
Pescara 61
Shenyang 60
Hebei 59
Munich 52
Dong Ket 49
Jiaxing 45
Hong Kong 42
Woodbridge 41
Moscow 40
New York 40
Tianjin 40
Washington 40
Norwalk 36
Vienna 31
Milan 29
São Paulo 29
Changsha 27
Pune 24
Hangzhou 23
Nuremberg 21
Grevenbroich 20
Jinan 20
San Mateo 19
Hefei 18
Augusta 17
Brussels 17
Orange 17
Zhengzhou 17
Chicago 16
Houston 16
Seattle 16
Ancona 15
Düsseldorf 15
Guangzhou 15
Helsinki 15
Brno 14
Kocaeli 14
Palermo 14
Civitanova Marche 13
Lanzhou 13
Auburn Hills 12
Falls Church 12
Teramo 12
Vittuone 12
Changchun 11
Shanghai 11
Spoltore 11
Catania 10
Ferrara 10
Napoli 10
Toronto 10
Amsterdam 9
Boston 9
Varallo 9
Warsaw 9
Brooklyn 8
London 8
Ningbo 8
Rio de Janeiro 8
San Francisco 8
Segrate 8
Stockholm 8
Tokyo 8
Dallas 7
Geneva 7
Mexico City 7
Simi Valley 7
Ascoli Piceno 6
Bologna 6
Chengdu 6
Chennai 6
Ciudad de Villa de Álvarez 6
Coimbatore 6
Council Bluffs 6
Dhaka 6
L'aquila 6
Melfi 6
Totale 10.097
Salva come PNG Salva come JPEG
Nome #
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 196
Streptococcus dysgalactiae subsp. equisimilis: two cases of tonsillitis. 162
Effetto post-antibiotico di levofloxacina e grepafloxacina nei confronti di Stenotrophomonas maltophilia. 160
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 139
Unusual oropharyngeal asymptomatic manifestations caused by atypical pathogens detected by PCR into altered ecosystems of an infertile couple. 136
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: Microbiological, clinical and economic evaluation 129
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 126
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 113
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 109
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 107
Colonic adenoma-associated Escherichia coli express specific phenotypes 107
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 104
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 102
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. 102
Monitoraggio microbiologico di aria e superfici in ambiente di prime cure chirurgiche di ambulatorio INAIL. 101
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 100
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 100
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 100
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. 98
Two cases of vaginitis caused by itraconazole-resistant saccharomyces cerevisiae and a review of recently published studies. 96
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 96
In vitro microbiology studies on a new peritoneal dialysis connector 95
A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). 95
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 94
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 93
Accuracy of flagella’s staining in the diagnosis of Helicobacter pylori infection: comparative study with the hystology, culture, and rapid urease test. 93
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 93
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 91
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 91
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients 90
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 90
Comparison of the E test to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori. 90
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 90
Produzione di biofilm in ceppi di Listeria monocytogenes isolati da matrice ittica: correlation con motilità ed idrofobicità cellulare. 89
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 89
Evaluation of the E Test for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Patients with Long-Term Bladder Catheterization 88
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 88
Accuratezza di Etest per lo studio di attività in vitro di combinazioni tra fluorochinoloni e cefalosporine di terza generazione verso Pseudomonas aeruginosa. 88
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 88
Salmonella typhimurium-endocarditis secondary to an acquired environmental infection: a case report. 87
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 87
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 87
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 87
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. 86
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori (T. Alarcon, D. Domingo, M. Lopez-Brea). Author’s Reply. 86
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 86
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 85
null 85
First report of an acute purulent maxillary sinusitis caused by Pseudomonas aeruginosa secondary to dental implant placement in an immunocompetent patient. 85
Antibiotico-resistenza di gram-negativi isolati in Terapia Intensiva nel triennio 1996-1998. 85
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 85
Isolamento di Actinobacillus actinomycetemcomitans nella placca sottogengivale di pazienti portatori di apparecchiature ortodontiche 85
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 85
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 84
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 84
Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report. 84
Sensibilità in vitro ai fluorichinoloni di Stenotrophomonas maltophilia isolati da pazienti neutropenici. 84
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 84
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 84
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods 83
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 83
Accuratezza di E test nella determinazione in vitro della sensibilità di stafilococchi isolati da pazienti neutropenici verso levofloxacina. 83
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 83
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 83
In Vitro Viability of External Eye Microbial Flora in Hydroxy-Propyl-Methylcellulose 82
Identificazione di ceppi di Acinetobacter baumannii appartenenti a cloni epidemici mediante sequenziamento di geni coinvolti nella produzione di biofilm. 82
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 82
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 82
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 82
Isolation of colistin-resistant Hafnia alvei. 82
Influenza di fattori abiotici sulla produzione di biofilm da parte di Stenotrophomonas maltophilia. 81
Effetto dello swimming e della idrofobicità superficiale di Stenotrophomonas maltophilia sull’adesività e sulla formazione di biofilm su polistirene. 81
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 81
Ottimale sopravvivenza di Actinobacillus actinomycetemcomitans sotto varie condizioni di trasporto. 81
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 81
Normal breathing releases SARS-CoV-2 into the air 81
Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheter-related fungemia. 80
Virulence factors of Stenotrophomonas maltophilia, an emergent pathogen associated to cystic fibrosis. 80
Valutazione dell’espressione delle oncoproteine di Papillomavirus nella gestione e nel triage delle donne in follow-up per lesioni di basso grado. 80
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 80
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 80
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 80
Attività in vitro di fluorochinoloni nei confronti del biofilm prodotto da Stenotrophomonas maltophilia. 79
Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. 79
Accuratezza di E test per il monitoraggio dell’antibiotico-sensibilità di Pseudomonas aeruginosa isolati da pazienti sottoposti a cateterismo vescicale. 79
Attività in vitro di levofloxacina verso isolati clinici da pazienti neutropenici. 79
Nuovi sistemi emocolturali automatici, ESP 128 (Difco) e Bact/Alert (Organon Teknika): analisi comparativa. 79
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 79
A case ofpharyngitis caused by Streptococcus pneumoniae. 79
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 79
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 78
An unexpected isolate of Hafnia alvei withreduced susceptibility to cefoxitin. 78
Multidrug-resistant Escherichia fergusonii: a case of acutecystitis. 77
Ricerca di Helicobacter pylori tramite PCR su biopsie gastriche sottoposte al test rapido all’ureasi (CP-test). 77
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 77
Methicillin-resistant Staphylococcus pseudintermedius infection in a bone marrow transplant recipient 77
Frequency of detection of Actinobacillus actinomycetemcomitans in young patients during fixed orthodontic therapy. 76
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 76
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 76
Contribution of the Leifson stain to the detection of Helicobacter pylori from antral biopsy specimens. 76
Totale 9.096
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 0 0 0 0 0 0 32
2020/20211.464 217 26 257 33 124 266 20 33 116 212 53 107
2021/20221.270 40 47 34 218 107 22 43 111 122 40 143 343
2022/20233.433 288 423 215 416 341 652 203 261 441 42 99 52
2023/20241.468 122 75 90 46 116 381 368 71 16 48 10 125
2024/20253.189 248 614 464 115 88 146 136 159 472 184 441 122
Totale 18.007